DMC

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Retrieved on: 
Tuesday, April 9, 2024
Neurology, Neuroprotection, Element, Conference call, Institutional review board, Cerebrospinal fluid, Survival, Disease, ALS, SPA, Bone marrow, CSF, Data monitoring committee, Webcast, Patient, Protocol, Biomarker, Mortality, Microsoft Exchange Server, Stem cell, DMC, Screening, Agency, Safety, CAFS, Brainstorm, Therapy, Marketing, FDA, BLA, Neuroinflammation, Food, Pharmaceutical industry

NEW YORK, April 9, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it received written agreement from the U.S. Food and Drug Administration (FDA), under a Special Protocol Assessment (SPA), on the design for a Phase 3b trial of NurOwn® in amyotrophic lateral sclerosis (ALS). 

Key Points: 
  • (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it received written agreement from the U.S. Food and Drug Administration (FDA), under a Special Protocol Assessment (SPA), on the design for a Phase 3b trial of NurOwn® in amyotrophic lateral sclerosis (ALS).
  • The SPA agreement with the FDA validates the clinical trial protocol and statistical analysis of the planned Phase 3b trial of NurOwn, demonstrating their adequacy for addressing objectives that support a future BLA (Biologics License Application) in ALS.
  • We appreciate the Agency's engagement and guidance during the SPA process and look forward to moving forward with the study."
  • The Phase 3b trial (Study BCT-006-US) will be a two-part, multicenter, study designed to assess the efficacy and safety of NurOwn in patients with ALS.

DMC Global Enters into Cooperation Agreement with Bradley L. Radoff

Retrieved on: 
Friday, March 15, 2024
Womble Bond Dickinson, Standstill, LLP, DMC, Annual general meeting, Financial adviser

BROOMFIELD, Colo., March 15, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today announced that the Company has entered into a cooperation agreement (the "Cooperation Agreement") with Bradley L. Radoff and his affiliate (the “Radoff Parties”), pursuant to which the Company and the Radoff Parties will identify and mutually agree to appoint a new independent director to the board of directors of DMC (the “Board”) with expertise and experience in the building products sector.

Key Points: 
  • BROOMFIELD, Colo., March 15, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today announced that the Company has entered into a cooperation agreement (the "Cooperation Agreement") with Bradley L. Radoff and his affiliate (the “Radoff Parties”), pursuant to which the Company and the Radoff Parties will identify and mutually agree to appoint a new independent director to the board of directors of DMC (the “Board”) with expertise and experience in the building products sector.
  • Pursuant to the terms of Cooperation Agreement, the Board will promptly commence a formal search for qualified director candidates, in accordance with DMC’s established process for director recruitment and with the aid of a nationally recognized executive search firm.
  • The Radoff Parties have agreed to certain customary provisions, including standstill and voting obligations.
  • Olshan Frome Wolosky LLP is serving as legal counsel and Longacre Square Partners is serving as strategic advisor to the Radoff Parties.

Cyberlux Corporation (OTC: CYBL) Releases 2023 Annual Report of Financial and Operational Results

Retrieved on: 
Monday, April 1, 2024
Defense, Technology, Telecommunications, Military, Other Defense, Contracts, Aircraft, CYBL, Department of Defence, Growth, Exercise, Fraction, Corporation, Acquisition, UAS, Completeness, Annual report, DMC, Bank statement, OTC, Aircraft systems, Government

Cyberlux Corporation CEO Mark Schmidt commented on the results: “2023 proved to be a noteworthy year with the strategic restructuring of all Cyberlux business units.

Key Points: 
  • Cyberlux Corporation CEO Mark Schmidt commented on the results: “2023 proved to be a noteworthy year with the strategic restructuring of all Cyberlux business units.
  • This initiative aimed to streamline operations and enhance the company's ability to deliver high-quality products and services to our customers.
  • The company reported the operations of these subsidiaries as a discontinued operation in the 2023 and 2022 financial statements.
  • For more information, please read the full 2023 Annual Report: https://www.otcmarkets.com/otcapi/company/financial-report/396408/content .

Imprinted Data Matrix Code on ams OSRAM LEDs now enables automotive manufacturers to streamline their production

Retrieved on: 
Friday, March 22, 2024
Semiconductor, Automotive, General Automotive, Automotive Manufacturing, Technology, Manufacturing, Temperature, Light-emitting diode, Ams-OSRAM, RGB, DMC, Electronics, OSRAM, Housing, LED, Data

The innovation, referred to as DMC (Data Matrix Code), is based on a unique, machine-readable code printed on top of each LED package.

Key Points: 
  • The innovation, referred to as DMC (Data Matrix Code), is based on a unique, machine-readable code printed on top of each LED package.
  • DMC is already available today for some members of the OSIRE® family of automotive LEDs.
  • The code on the package links to individual data for each LED production unit: color coordinates, luminous intensity and forward voltage at two currents.
  • Anita Wenzl, Senior Product Marketing Manager of ams OSRAM, emphasizes: ”ams OSRAM was the first LED manufacturer to provide a link to the measurement data of each individual LED through a code printed onto the LED itself.

Early Smiles Sacramento to Honor School Health Staff at Its Second Annual “Heroes in Health Services” Reception

Retrieved on: 
Tuesday, March 12, 2024
Teens, Children, Dental, Managed Care, General Health, Preschool, Consumer, Health, Primary, Secondary, Education, Health care, Dietitian, Achievement Medal, COVID-19, Golden, DMC, Student, Safety, Oral hygiene, Dentistry

Early Smiles Sacramento, a school-based oral health screening initiative developed by the Center for Oral Health, is proud to announce the hosting of its second annual Heroes in Health Services Reception.

Key Points: 
  • Early Smiles Sacramento, a school-based oral health screening initiative developed by the Center for Oral Health, is proud to announce the hosting of its second annual Heroes in Health Services Reception.
  • This prestigious event is dedicated to recognizing the unwavering commitment and resilience of school health personnel throughout Sacramento County.
  • Tiffany Turner, Chief Operating Officer of the Center for Oral Health, expressed her enthusiasm about the upcoming event, stating, "We are thrilled to honor the remarkable efforts of school health services staff.
  • The Early Smiles Sacramento Heroes in Health Services Reception is scheduled for Thursday, April 4, 2024, from 5:00 PM to 8:00 PM.

509 Releases Bold New Products for Motorcycle Riders in the 2024 Street Collection

Retrieved on: 
Thursday, April 4, 2024
Ardor, Street Riders, DMC, Collection, Shoe, Chin, Mach 5, Breathability, JBL, Mach, Shoemaking

SPOKANE, Wash., April 4, 2024 /PRNewswire/ -- 509, a leading outdoor performance apparel brand, announces the release of the 2024 Street Collection. Relentlessly driven by their passion for riding, 509's newest Street offerings include new industry-leading, communications-integrated helmet designs; performance riding gear including a modular helmet, riding shoes, and full-leather gloves all crafted to allow any motorcyclists to fully immerse themselves in the ride.

Key Points: 
  • The 2024 Street Collection offers head-to-toe riding protection for motorcycle riders including new industry-disrupting helmets, riding gloves, and shoes each designed with Street Riders in mind.
  • SPOKANE, Wash., April 4, 2024 /PRNewswire/ -- 509, a leading outdoor performance apparel brand, announces the release of the 2024 Street Collection.
  • "We are thrilled to introduce our latest seasonal lineup focused on providing our riders with innovative, head-to-toe products and best-in-class experiences," says Andy Berg, Street Product Line Manager.
  • Highlights from the 509 Street 2024 Collection include:
    509's newest addition to the lineup is the fully modular, Mach IV Mod Helmet completing the Mach family of full-faced performance helmets.

Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed

Retrieved on: 
Thursday, March 7, 2024
Data monitoring committee, SUSAR, DMC, Adverse effect, IRB, Fatty liver disease, Patient, United, NASH, ICF, Euronext Paris

Inventiva has lifted the voluntary pause on screening and randomization in the NATiV3 clinical trial following the approval from the US central IRB of the amended protocol and ICF.

Key Points: 
  • Inventiva has lifted the voluntary pause on screening and randomization in the NATiV3 clinical trial following the approval from the US central IRB of the amended protocol and ICF.
  • Other sites and countries are expected to resume screening and randomization activities progressively over the next weeks.
  • Clinical sites located in the United States operating under central IRB have meanwhile resumed screening and randomization activities.
  • Inventiva anticipates the last patient first visit for the NATiV3 clinical trial in the first half of 2024.

G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Retrieved on: 
Wednesday, February 28, 2024
G1 Therapeutics, Breast cancer, Carboplatin, Research, PIN, SCLC, Telephone, Update, J. P. Morgan, DMC, Food, Growth, SACT, G1, Trilaciclib, Hospital, ADC, OS, Conjugation, GAAP, Event, Therapy, Webcast, Patent, Patient, Acceleration, Clinical trial, Survival, Oncology, ITT, Pharmaceutical industry

G1 recognized total revenues of $14.9 million and $82.5 million for the fourth quarter and full year of 2023, respectively.

Key Points: 
  • G1 recognized total revenues of $14.9 million and $82.5 million for the fourth quarter and full year of 2023, respectively.
  • Operating expenses for the fourth quarter of 2023 were $23.8 million, compared to $41.1 million for the fourth quarter of 2022.
  • Research and development (R&D) expenses for the fourth quarter of 2023 were $7.4 million, compared to $16.6 million for the fourth quarter of 2022.
  • The net loss for the fourth quarter of 2023 was $10.9 million, compared to $33.6 million for the fourth quarter of 2022.

DMC Global Reports Fourth Quarter Financial Results

Retrieved on: 
Thursday, February 22, 2024
CFO, NCI, DMC, Growth, Toyota Dyna, Southwestern United States, Automation, Video game

Fourth quarter sales were $174.0 million, flat versus Q4 2022

Key Points: 
  • Fourth quarter sales were $174.0 million, flat versus Q4 2022
    Net income attributable to DMC was $2.8 million, while total net income was $3.6 million
    Adjusted net income attributable to DMC* was $5.2 million, or $0.26 per diluted share
    Adjusted EBITDA attributable to DMC* was $19.6 million, while total adjusted EBITDA, inclusive of non-controlling interest (NCI), was $23.3 million
    Full-year results include record sales, adjusted EBITDA attributable to DMC, and free-cash flow performance
    BROOMFIELD, Colo., Feb. 22, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today reported financial results for its fourth quarter ended December 31, 2023.
  • Michael Kuta, president and CEO, said, “The fourth quarter marked the end of a milestone year for DMC.
  • Arcadia’s fourth quarter sales were $68.0 million, down 9% from the 2022 fourth quarter.
  • Dyna’s fourth quarter sales were $75.3 million, down 3% versus the 2022 fourth quarter, but up 3% sequentially.

Arcitecta Honored for Advanced Data Management Solution that Delivers High-speed File Transfers over Vast Distances and High Latency Networks

Retrieved on: 
Monday, February 19, 2024
Data Management, Technology, Software, Other Science, Research, Science, Cloud, Transfer, HPC, Architecture, Innovation, Light, NCI, National Computational Infrastructure, DMC, Data management, International Convention Centre Sydney, Aero, Metadata, Organization, Associate, Creativity, Ecosystem, SCA, Video game

Arcitecta will also participate in the AeRO Forum: Road Testing a Research Data Reference Architecture on February 21, 2024, from 1:30 – 5:30 p.m. in Meeting Room C2.3 at the International Convention Centre Sydney.

Key Points: 
  • Arcitecta will also participate in the AeRO Forum: Road Testing a Research Data Reference Architecture on February 21, 2024, from 1:30 – 5:30 p.m. in Meeting Room C2.3 at the International Convention Centre Sydney.
  • It leverages the power of metadata to optimize data movement via parallelized data transfers across latent networks and eliminate redundant file transfers.
  • DMC challenges international teams to develop the most advanced and innovative solutions for data transfer across servers located in various countries connected by 100Gbps international research and education networks.
  • The challenge focuses on optimizing point-to-point data transfers between sites – a crucial step in advancing research collaboration and sharing.